Evidence map›Paper›PMID 32171076›Full record

ArticleLancet (London, England)2020

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Fei Zhou, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, Zhibo Liu, Jie Xiang, Yeming Wang, Bin Song, Xiaoying Gu and 9 more

Erratum issued 106 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 106 registered trials, which are not on this map. Cited by 14,993 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14,993citing papers in PubMed, 5 pooled it
678.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04320277 phase2 / phase3unknown statusnot on this map

Baricitinib Combined With Antiviral Therapy in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study

TypeinterventionalSponsorHospital of PratoRan2020 to 2020Enrolled200ConditionsPharmacological ActionArmsBaricitinib
NCT04324684 completednot on this map

Time of Recovery and Prognostic Factors of COVID-19 Pneumonia

TypeobservationalSponsorCatholic University of the Sacred HeartRan2020 to 2020Enrolled198ConditionsPneumonia, Viral, Hypertension, Diabetes Mellitus, Obesity
NCT04327505 phase2 / phase3terminatednot on this map

A Randomized, Controlled, Open Label, Multicentre Clinical Trial to Explore Safety and Efficacy of Hyperbaric Oxygen for Preventing ICU Admission, Morbidity and Mortality in Adult Patients With COVID-19

TypeinterventionalSponsorKarolinska InstitutetRan2020 to 2022Enrolled34ConditionsSARS (Severe Acute Respiratory Syndrome), Cytokine Storm, ARDS, Human, COVID-19ArmsHyperbaric oxygen
NCT04333875 completednot on this map

Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis - a Collateral Effect of the SARS-CoV-2 Pandemic (AS DEFER)

Typeobservational_patient_registrySponsorInsel Gruppe AG, University Hospital BernRan2020 to 2021Enrolled71ConditionsAortic Valve StenosisArmsTAVR or SAVR
NCT04335071 phase2terminatednot on this map

CORON-ACT - a Multicenter, Double-blind, Randomized Controlled Phase II Trial on the Efficacy and Safety of Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)

TypeinterventionalSponsorInsel Gruppe AG, University Hospital BernRan2020 to 2020Enrolled5ConditionsSARS-CoV-2 InfectionArmsTocilizumab (TCZ), Placebo
NCT04336384 completednot on this map

Impact of Covid-19 in Congenital Heart Disease - COVID-CHD

TypeobservationalSponsorUniversity Hospital, MontpellierRan2020 to 2020Enrolled5,000ConditionsCongenital Heart Disease, Covid-19
NCT04337983 completednot on this map

Hemodynamic Characteristics of Patients With SARS-CoV-2: PiCCOVID Study

TypeobservationalSponsorBicetre HospitalRan2020 to 2020Enrolled60ConditionsCoronavirus, SARS-CoV-2, COVID-19, Acute Respiratory Distress SyndromeArmsTranspulmonary thermodilution, Echocardiography
NCT04338009 nacompletednot on this map

The Randomized Elimination or Prolongation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Coronavirus Disease 2019

TypeinterventionalSponsorUniversity of PennsylvaniaRan2020 to 2020Enrolled152ConditionsCOVID-19ArmsDiscontinuation of ARB/ACEI, Continuation of ARB/ACEI
NCT04339816 phase3terminatednot on this map

Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care Due to Coronavirus Disease 2019 (COVID-19)- Randomised Controlled Trial

TypeinterventionalSponsorFrantisek Duska, MD, PhDRan2020 to 2020Enrolled3ConditionsCOVID-19, Respiratory FailureArmsAzithromycin, Hydroxychloroquine, Placebo
NCT04340921 withdrawnnot on this map

The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury

TypeobservationalSponsorBarts & The London NHS TrustRan2020 to 2023Enrolled0ConditionsCardiovascular Disease Acute, Cardiomyopathies, COVIDArmsCOVID-19 exposure
NCT04349592 nacompletednot on this map

Randomized Placebo-controlled Trial of Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19

TypeinterventionalSponsorHamad Medical CorporationRan2020 to 2020Enrolled456ConditionsCovid19ArmsHydroxychloroquine, Azithromycin, Placebo Tablet, Placebo capsules
NCT04352400 phase2 / phase3unknown statusnot on this mapstarted 2021, after this paper: background citation

RAndomized Clinical Trial in COvid19 Patients to Assess the Efficacy of the Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor NAfamostat (RACONA Study)

TypeinterventionalSponsorUniversity Hospital PadovaRan2021 to 2024Enrolled256ConditionsCOVID19ArmsNafamostat Mesilate, Placebo
NCT04355247 phase2unknown statusnot on this map

Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm

TypeinterventionalSponsorAuxilio Mutuo Cancer CenterRan2020 to 2021Enrolled20ConditionsCovid-19ArmsMethylPREDNISolone 80 Mg/mL Injectable Suspension
NCT04355507 completednot on this map

Computed Tomography for Coronavirus Disease 19 Diagnosis

TypeobservationalSponsorAssistance Publique - Hôpitaux de ParisRan2020 to 2020Enrolled10,735ConditionsCOVID-19ArmsChest computed tomography (CT), Reverse-transcription polymerase chain reaction (RT-PCR)
NCT04358029 completednot on this map

Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19)

TypeobservationalSponsorVivek ReddyRan2020 to 2023Enrolled4,000ConditionsCOVID 19 Cardiac, COVID 16 Arrhythmia, COVID 19 Death
NCT04359290 phase2completednot on this map

Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS A Single-arm, Open-label, Proof of Concept Study

TypeinterventionalSponsorPhilipps University MarburgRan2020 to 2021Enrolled15ConditionsARDS, Human, COVIDArmsRuxolitinib administration
NCT04359797 nacompletednot on this map

Pragmatic Trial Exploring Impact of Patient Positioning in the Management of Patients Infected With COVID-19: Supine vs. Prone

TypeinterventionalSponsorVanderbilt University Medical CenterRan2020 to 2021Enrolled501ConditionsCOVID-19ArmsProne, Usual Care
NCT04363463 nacompletednot on this map

Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress

TypeinterventionalSponsorCentre Hospitalier Régional d'OrléansRan2020 to 2022Enrolled268ConditionsCOVID19, Oxygen Therapy, Prone Position, Spontaneous VentilationArmsprone position
NCT04365725 completednot on this map

Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections.

TypeobservationalSponsorAssistance Publique - Hôpitaux de ParisRan2020 to 2020Enrolled84ConditionsCOVID-19ArmsRemdesivir
NCT04367207 unknown statusnot on this map

African Covid-19 Critical Care Outcomes Study: An African, Multi-centre Evaluation of Patient Care and Clinical Outcomes for Patients With COVID-19 Admitted to High-care or Intensive Care Units

Typeobservational_patient_registrySponsorUniversity of Cape TownRan2020 to 2020Enrolled2,000ConditionsSevere Acute Respiratory Syndrome Coronavirus 2
NCT04369820 nacompletednot on this map

C5a Receptor Expression in Circulating Myeloid Cells in ARDS Secondary to COVID-19

TypeinterventionalSponsorAssistance Publique Hopitaux De MarseilleRan2020 to 2023Enrolled61ConditionsCOVID-19Armsdraw blood
NCT04372979 phase3terminatednot on this map

Evaluation Of Efficacy Of COVID-19 Convalescent Plasma Versus Standard Plasma In The Early Care Of COVID-19 Patients Hospitalized Outside Intensive Care Units.

TypeinterventionalSponsorDirection Centrale du Service de Santé des ArméesRan2020 to 2021Enrolled18ConditionsCOVID-19ArmsTransfusion of SARS-CoV-2 Convalescent Plasma., Transfusion of standard Plasma.
NCT04373135 nacompletednot on this map

A Study to Evaluate Health Behavior and Access Impacts Due to COVID-19 and for Community Engagement of Stakeholders Surrounding Scarce Resource Allocation Policy.

TypeinterventionalSponsorUniversity of California, Los AngelesRan2020 to 2021Enrolled1,971ConditionsCovid-19, Critical Illness, Attitude of Health Personnel, Attitude to HealthArmsBrief educational video
NCT04375670 completednot on this map

COVID19-FOIE National Observatory. An Ambispective Cohort Study of All Consecutive Patients

TypeobservationalSponsorAssistance Publique - Hôpitaux de ParisRan2020 to 2022Enrolled1,132ConditionsLiver Diseases, COVID19
NCT04375709 unknown statusnot on this map

Health-related Quality of Life (HRQOL) and Physical Performance in Individuals After COVID-19 Induced Hospitalisation and the Impact of a Standard Care Follow-up Program: a Longitudinal Observational Cohort Study

TypeobservationalSponsorKantonsspital Winterthur KSWRan2020 to 2021Enrolled60ConditionsCovid-19 (New Coronavirus) InfectionArmsPhysical exercise, Education sessions
NCT04379076 phase2terminatednot on this map

A Multicenter, Randomized, Double-blinded Placebo-controlled Study of Recombinant Interleukin-7 (CYT107) for Immune Restoration of Hospitalized Lymphopenic Patients With Coronavirus COVID-19 Infection in UK

TypeinterventionalSponsorRevimmuneRan2020 to 2022Enrolled35ConditionsCOVID-19, LymphocytopeniaArmsInterleukin-7, Placebos
NCT04379258 completednot on this mapstarted 2021, after this paper: background citation

Epidemiological Analysis of the Mortality of Critically Ill Patients With the COVID-19 Admitted to the Intensive Care Unit: An Observational, Prospective and Multicenter Study

Typeobservational_patient_registrySponsorHospital Universitario GetafeRan2021 to 2021Enrolled868ConditionsCOVID-19, Critical Illness, Effectiveness, Outcome, Fatal
NCT04380662 unknown statusnot on this map

RRisk Factors Worsening COVID19 (Coronavirus Infectious Disease 2019) for Outpatient With Home Monitoring (COVID-A-DOMEVA Study)

TypeobservationalSponsorUniversity Hospital, GrenobleRan2020 to 2020Enrolled800ConditionsCovid19ArmsRisk factors
NCT04380727 completednot on this map

Almitrine and Severe COVID-19 Patients in ICU [Almitrine et Patients COVID-19 en Reanimation (French)]

Typeobservational_patient_registrySponsorCentral Hospital, Nancy, FranceRan2020 to 2020Enrolled17ConditionsCOVID-19, Hypoxic Respiratory Failure
NCT04381312 unknown statusnot on this map

COVID-19 Chez la Personne âgée de Plus de 70 Ans : Impact Direct et Indirect à 3 Mois.

TypeobservationalSponsorUniversity Hospital, GrenobleRan2020 to 2021Enrolled1,000ConditionsRisk Factors for COVID-19 Outcomes in Elderly Populations
NCT04390555 unknown statusnot on this map

COVID-19 in Hospitalised Patients With Preexisting CArdioVascular Diseases and/or Cardiac Involvement and/or Cardiovascular Risk Factors: the Global PCHF-COVICAV Registry

Typeobservational_patient_registrySponsorUniversity of ZurichRan2020 to 2021Enrolled1,500ConditionsCOVID-19, Cardiovascular Diseases, Cardiovascular Risk Factor, Heart Failure
NCT04395482 completednot on this map

Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury by Machine Learning: a Multicenter Retrospective Cohort Study.

TypeobservationalSponsorUniversity of Milano BicoccaRan2020 to 2022Enrolled44Conditionscovid19ArmsLung CT scan analysis in COVID-19 patients
NCT04401436 completednot on this map

COVID-19-Associated Lymphopenia Pathogenesis Study in Blood

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2020 to 2025Enrolled240ConditionsCoronavirus Disease 2019
NCT04402203 phase2 / phase3unknown statusnot on this map

Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh

TypeinterventionalSponsorBangladesh Medical Research Council (BMRC)Ran2020 to 2020Enrolled50ConditionsCOVID-19, Favipiravir (Favipira)ArmsFavipiravir, Only Standard Treatment
NCT04407169 completednot on this map

Evaluation of the Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease Hospitalized for Severe Forms

TypeobservationalSponsorCentral Hospital, Nancy, FranceRan2020 to 2020Enrolled617ConditionsCOVIDArmsno intervention
NCT04407689 phase2terminatednot on this map

A Multicenter, Randomized, Double-blinded Placebo-controlled Study of Recombinant Interleukin-7 (CYT107) for Immune Restoration of Hospitalized Lymphopenic Patients With Coronavirus COVID-19 Infection in France and Belgium

TypeinterventionalSponsorRevimmuneRan2020 to 2022Enrolled34ConditionsCOVID-19, LymphocytopeniaArmsInterleukin-7, Placebo
NCT04409899 unknown statusnot on this map

The Utility of Enhanced Pre- and Post-surgical Protocols to Prevent the Spread of COVID-19 in a Large Urological Department (UroCovid Study)

TypeobservationalSponsorFundacio PuigvertRan2020 to 2020Enrolled300ConditionsCOVID-19, Urologic Diseases, Surgery--Complications, Epidemic DiseaseArmsBlood tests
NCT04410549 nacompletednot on this map

Optical Coherence Tomography for Microvascular Lung Vessels Obstructive Thromboinflammatory Syndrome Assessment in Patients With COVID-19: an Exploratory Study

TypeinterventionalSponsorIRCCS San RaffaeleRan2020 to 2021Enrolled13ConditionsCovid19, Pulmonary EmbolismArmsOptical Coherence Tomography (OCT)
NCT04412226 completednot on this map

Effect of Using Barrier Devices for Intubation in COVID-19 Patients: Randomized, Prospective, Manikin Study

TypeobservationalSponsorDerince Training and Research HospitalRan2020 to 2020Enrolled13ConditionsIntubation, Intratracheal, COVID-19Armsaerosol box, transparent sheet
NCT04420312 completednot on this map

Incidence and Characteristics of Pulmonary Embolism in COVID-19 Patients Hospitalized for Acute Respiratory Syndrome

TypeobservationalSponsorFondation Hôpital Saint-JosephRan2020 to 2020Enrolled1,024ConditionsPulmonary Embolism, Covid-19
NCT04424953 nacompletednot on this map

A Randomised Controlled Trial to Compare McGrath Videolaryngoscope Against Direct Laryngoscope for Endotracheal Intubation When Powered Air Purifying Respirator is Worn During the Current Coronavirus Disease 2019 Pandemic

TypeinterventionalSponsorSingapore General HospitalRan2020 to 2020Enrolled28ConditionsCoronavirus Infection, Ventilatory Failure, Anesthesia Intubation ComplicationArmsMcGrath videolaryngoscope, Direct laryngoscope
NCT04425720 nacompletednot on this map

Use of Remote Patient Monitoring (RPM) Platform for COVID-19 Patient

TypeinterventionalSponsorMontefiore Medical CenterRan2020 to 2021Enrolled300ConditionsCOVIDArmsLifeSignals Biosensor 1AX*, Standard of Care
NCT04426201 phase2terminatednot on this map

A Multicenter, Randomized, Double-blinded Placebo-controlled Study of Recombinant Interleukin-7 (CYT107) for Immune Restoration of Hospitalized Lymphopenic Patients With Coronavirus COVID-19 Infection. US Oncology Cohort

TypeinterventionalSponsorRevimmuneRan2020 to 2022Enrolled10ConditionsCOVID-19, LymphocytopeniaArmsCYT107, Placebo
NCT04427566 phase2terminatednot on this map

Vented COVID: A Phase II Study Of The Use Of Ultra Low-Dose Bilateral Whole Lung Radiation Therapy in the Treatment Of Critically Ill Patients With COVID-19 Respiratory Compromise

TypeinterventionalSponsorOhio State UniversityRan2020 to 2021Enrolled2ConditionsCOVID-19ArmsRadiation therapy
NCT04432103 phase3terminatednot on this map

Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma

TypeinterventionalSponsorCentro Medico ABCRan2020 to 2021Enrolled6ConditionsCovid-19ArmsAnti SARS-CoV 2 Convalescent Plasma in severe COVID-19 patients, Anti SARS-CoV 2 Convalescent Plasma in critical COVID-19 patients
NCT04433026 unknown statusnot on this map

B-natriuretic Peptide (BNP), Serum Troponin-I, and D-dimer as Risk Factors for In-hospital Death in Patients With COVID-19

TypeobservationalSponsorAssiut UniversityRan2020 to 2021Enrolled90ConditionsCOVID-19ArmsN terminal pro B type natriuretic peptide (NTproBNP), D-Dimer, and serum Tropinin - I
NCT04438629 unknown statusnot on this map

Evaluation of Immune Response in COVID-19 Patients

TypeobservationalSponsorAzienda Ospedaliera Universitaria Integrata VeronaRan2020 to 2020Enrolled80ConditionsAllergy and Immunology, Infection ViralArmsCOVID-19 treatment
NCT04442178 phase2terminatednot on this map

A Multicenter, Randomized, Double-blinded Placebo-controlled Study of Recombinant Interleukin-7 (CYT107) for Immune Restoration of Hospitalized Lymphopenic Patients With Coronavirus COVID-19 Infection. US Infectious Cohort

TypeinterventionalSponsorRevimmuneRan2020 to 2022Enrolled26ConditionsCOVID-19, LymphocytopeniaArmsCYT107, Placebo
NCT04447131 completednot on this map

Effect of SARS-CoV-2 Infection on Platelet Aggregation and Other Coagulation Parameters

TypeobservationalSponsorUniversity of Sao PauloRan2020 to 2023Enrolled120ConditionsCOVID-19, SARS-CoV-2Armsvenipuncture in peripheral vein
NCT04447144 unknown statusnot on this map

Nutritional Habits, Does it Affect Coronavirus Disease 2019 (COVID-19) Infection Outcome? An Egyptian Experience

TypeobservationalSponsorCairo UniversityRan2020 to 2020Enrolled200ConditionsCovid19, Chronic Inflammation, Non-Communicable Chronic Diseases
NCT04456426 withdrawnnot on this mapstarted 2021, after this paper: background citation

Evaluation of the Characteristics of Patients With Suspected or Confirmed of COVID-19 in Villavicencio and Meta State, Colombia

TypeobservationalSponsorHospital Departamental de VillavicencioRan2021 to 2021Enrolled0ConditionsCOVID, SARS-CoV 2, SARS Pneumonia, SARS (Disease)
NCT04465552 completednot on this map

Arrhythmic Manifestations and Management Strategies in Hospitalized COVID-19 Patients: Proposal for a Multicenter Registry

TypeobservationalSponsorKansas City Heart Rhythm Research FoundationRan2020 to 2021Enrolled666ConditionsCoronavirus InfectionsArmsPatients received standard of care treatment during hospitalization
NCT04475471 unknown statusnot on this map

WHF COVID-19 and Cardiovascular Disease Survey

TypeobservationalSponsorPublic Health Foundation of IndiaRan2020 to 2023Enrolled5,200ConditionsCOVID-19, Cardiovascular Diseases
NCT04479202 phase4completednot on this map

The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19

TypeinterventionalSponsorChinese Medical AssociationRan2020 to 2020Enrolled76ConditionsBerberine, COVID-19ArmsBerberine, Montmorrillonite
NCT04482621 phase2suspendednot on this map

Decitabine for COVID-19 Pneumonia-ARDS Treatment: DART Trial

TypeinterventionalSponsorJohns Hopkins UniversityRan2020 to 2026Enrolled33ConditionsCOVID-19ArmsDecitabine, Placebo Saline
NCT04489446 phase1 / phase2completednot on this map

Sildenafil for Treating Patients With COVID-19 and Perfusion Mismatch: A Pilot Randomised Trial

TypeinterventionalSponsorUniversidad Nacional Andres BelloRan2020 to 2021Enrolled40ConditionsCovid19, SARS-COV2 InfectionArmsSildenafil, Placebo
NCT04505774 phase4completednot on this map

A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic and Additional Strategies in Hospitalized Adults With COVID-19

TypeinterventionalSponsorMatthew Neal MDRan2020 to 2024Enrolled3,591ConditionsCovid19Armstheraputic heparin, prophylactic heparin, P2Y12, Crizanlizumab Injection, SGLT2 inhibitor
NCT04508985 nacompletednot on this map

Management of Renin-Angiotensin-Aldosterone System Blockade in Patients Admitted in Hospital With Confirmed Coronavirus Disease (COVID-19) Infection: The McGill RAAS-COVID-19 Randomized Controlled Trial

TypeinterventionalSponsorMcGill University Health Centre/Research Institute of the McGill University Health CentreRan2020 to 2021Enrolled46ConditionsCOVID-19, Cardiovascular DiseasesArmsTemporarily holding the RAAS inhibitor [intervention], RAAS inhibitor [continued standard of care]
NCT04513158 phase2terminatednot on this map

Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection

TypeinterventionalSponsorJoseph M. Flynn, D.O., MPHRan2020 to 2021Enrolled2ConditionsCovid19ArmsConvalescent Plasma
NCT04513470 phase1unknown statusnot on this map

A Multi-Center, Open-Label Study, Evaluating Safety of Allocetra-OTS for the Prevention of Organ-Failure Deterioration in Severe Patients With COVID-19 and Respiratory Dysfunction

TypeinterventionalSponsorHadassah Medical OrganizationRan2020 to 2021Enrolled5ConditionsCOVID-19ArmsAllocetra-OTS
NCT04513964 withdrawnnot on this map

Impact of COVID-19 on the Benefit of Cardiac Rehabilitation

TypeobservationalSponsorFondation Hôpital Saint-JosephRan2020 to 2022Enrolled0ConditionsHeart Failure, Covid19
NCT04517396 phase2completednot on this map

FEnofibRate as a Metabolic INtervention for Coronavirus Disease 2019

TypeinterventionalSponsorUniversity of PennsylvaniaRan2020 to 2022Enrolled701ConditionsCovid19ArmsFenofibrate/fenofibric acid, Placebo, Usual care
NCT04530448 phase4terminatednot on this map

Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization

TypeinterventionalSponsorWest Virginia UniversityRan2020 to 2021Enrolled3ConditionsCOVID, Coronavirus, Coronavirus Infection, AKIArmsSodium bicarbonate, Standard of Care
NCT04530578 phase4unknown statusnot on this map

Efficacy and Safety Study to Evaluate the Use of Nebulized Heparin in Patients With Severe Acute Respiratory Syndrome Covid-19 (SARS-CoV-2)

TypeinterventionalSponsorClinica San Camilo, ArgentinaRan2020 to 2021Enrolled200ConditionsCovid19, PneumoniaArmsHeparin sodium, Enoxaparin
NCT04547283 nacompletednot on this map

Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19: A Pilot Randomized Controlled Trial

TypeinterventionalSponsorWake Forest University Health SciencesRan2020 to 2020Enrolled40ConditionsCovid19, Respiratory FailureArmsUsual Care, APPS
NCT04554979 completednot on this map

Corona Virus (COVID-19) Disease Duration and Gastrointestinal Tract (GIT) Manifestations; Can be New Disease Severity Classification. A Pilot Egyptian Single National Center Experience

TypeobservationalSponsorCairo UniversityRan2020 to 2020Enrolled199ConditionsCovid19, DiarrheaArmsHydroxychloroquine Pill
NCT04587258 unknown statusnot on this map

Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island: A Community Based Quality Improvement Project of the Lifespan Cancer Institute

TypeobservationalSponsorRhode Island HospitalRan2020 to 2022Enrolled100ConditionsBreast Cancer, Colorectal Cancer, Covid19ArmsInformational videos and social media campaigns encouraging cancer screening.
NCT04596839 phase2completednot on this map

Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19): An Open Label, Multi-Center, Randomized Controlled Trial

TypeinterventionalSponsorDr. Md. Alimur RezaRan2020 to 2021Enrolled60ConditionsCovid19ArmsRemdesivir, Standard of Care
NCT04598334 unknown statusnot on this mapstarted 2022, after this paper: background citation

Investigating the Inflammatory Cytokines and Cytokine Storm Among Bangladeshi Patients With COVID-19: a Prospective, Observational Study

TypeobservationalSponsorInternational Centre for Diarrhoeal Disease Research, BangladeshRan2022 to 2022Enrolled75ConditionsCytokine Storm, COVID-19
NCT04611269 completednot on this map

Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in Argentina: a Prospective, Multicenter Cohort Study

Typeobservational_patient_registrySponsorArgentinian Intensive Care SocietyRan2020 to 2020Enrolled950ConditionsRespiratory Failure, Covid-19, Mechanical Ventilation
NCT04617119 naunknown statusnot on this map

The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU: A Pilot Study

TypeinterventionalSponsorDR. JASSIM ALGHAITHRan2020 to 2021Enrolled38ConditionsCovid19, Severe Systemic Illness Respiratory Muscle FatigueArmsThreshold IMT device, Conventional physical therapy
NCT04623177 completednot on this map

Effectiveness of Thromboprophylaxis With Low Molecular Weight Heparin in Critically Ill Patients With COVID-19. A Prospective, Cohort, Multicenter Study.

TypeobservationalSponsorInstituto de Investigacion Sanitaria La FeRan2020 to 2020Enrolled822ConditionsCovid19, Anticoagulant Therapy, Thrombosis
NCT04632732 completednot on this map

Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19).

Typeobservational_patient_registrySponsorCentre de recherche du Centre hospitalier universitaire de SherbrookeRan2020 to 2021Enrolled140ConditionsCovid19ArmsCOVID-19 test, Blood sampling
NCT04636086 phase4completednot on this map

Vitamin D Supplementation and Covid-19: a Randomised, Double- Blind, Controlled Study

TypeinterventionalSponsorUniversity of LiegeRan2020 to 2022Enrolled50ConditionsCovid19ArmsCholecalciferol, Placebo
NCT04646655 phase3completednot on this map

Enoxaparin at Prophylactic or Therapeutic Doses With Monitoring of Outcomes in Subjects Infected With COVID-19: a Pilot Study on 300 Cases Enrolled at ASST-FBF-Sacco

TypeinterventionalSponsorASST Fatebenefratelli SaccoRan2020 to 2023Enrolled142ConditionsCovid19, ThrombosisArmsEnoxaparin
NCT04682093 unknown statusnot on this map

Risk Stratification of Patients With Suspected COVID-19 Presenting to the ED (EUROCOV Study)

TypeobservationalSponsorEuropean Society for Emergency Medicine (EUSEM) Research NetworkRan2020 to 2021Enrolled8,000ConditionsCovid19
NCT04689711 completednot on this map

Generalizable Prognostic Models for Patient-Centered Decisions in COVID-19

TypeobservationalSponsorTufts Medical CenterRan2020 to 2021Enrolled21ConditionsCovid19
NCT04704544 nacompletednot on this mapstarted 2021, after this paper: background citation

Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis

TypeinterventionalSponsorUniversity of Alabama at BirminghamRan2021 to 2026Enrolled652ConditionsRheumatic DiseasesArmsTele-rheumatology
NCT04705766 recruitingnot on this mapstarted 2021, after this paper: background citation

The KIDCOV Study: ASSESSMENT of SARS-CoV-2 Without HOSPITALIZATION as a RISK FACTOR for ACUTE KIDNEY INJURY

Typeobservational_patient_registrySponsorUniversity of California, San FranciscoRan2021 to 2027Enrolled2,000ConditionsSARS-CoV Infection, Covid19, Corona Virus Infection, Acute Kidney InjuryArmsUrine Collection
NCT04712279 phase2 / phase3unknown statusnot on this mapstarted 2021, after this paper: background citation

High-Dose Ivermectin for Mild-to-Moderate COVID-19 - The (HD)IVACOV Trial

TypeinterventionalSponsorCorpometria InstituteRan2021 to 2021Enrolled294ConditionsCovid19ArmsIvermectin 0.6mg/kg/day, Ivermectin 1.0mg/kg/day, Placebo, Hydroxychloroquine
NCT04716985 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care. Double-blind, Randomized, Comparative Study

TypeinterventionalSponsorAGIR à DomRan2021 to 2023Enrolled700ConditionsSARS-CoV-2, Covid19, AMBULATORY CAREArmsMOLECULAR HYDROGEN, PLACEBO MAGNESIUM
NCT04730856 nacompletednot on this mapstarted 2021, after this paper: background citation

Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)

TypeinterventionalSponsorHospital Universitario Infanta LeonorRan2021 to 2021Enrolled311ConditionsCovid19, ThrombosisArmsTinzaparin
NCT04771000 phase2terminatednot on this mapstarted 2021, after this paper: background citation

A Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Ambrisentan in Patients With Severe COVID-19

TypeinterventionalSponsorNoorik Biopharmaceuticals AGRan2021 to 2023Enrolled88ConditionsCovid19, HypoxemiaArmsAmbrisentan, Placebo
NCT04794062 completednot on this map

Myocardial Injury and Quality of Life in Patients Recovered From the Pneumonia Associated With the Novel Coronavirus Infectious Disease COVID-19

TypeobservationalSponsorVoronezh Regional Clinical Consultative and Diagnostic CenterRan2020 to 2021Enrolled119ConditionsCOVID-19, Myocardial Injury, Myocarditis Post Infection
NCT04836780 phase3unknown statusnot on this mapstarted 2021, after this paper: background citation

DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia and High Risk of Developing Acute Respiratory Distress Syndrome

TypeinterventionalSponsorHospital Universitario Infanta LeonorRan2021 to 2023Enrolled126ConditionsCOVID-19, Acute Respiratory Distress Syndrome, Pneumonia, ViralArmsDexamethasone
NCT04884776 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Modulation of Gut Microbiota to Enhance Health and Immunity of Vulnerable Individuals During COVID-19 Pandemic

TypeinterventionalSponsorChinese University of Hong KongRan2021 to 2024Enrolled453ConditionsGut Microbiota, COVID-19 VaccineArmsMicrobiome immunity formula, Active placebo
NCT04896918 completednot on this map

Smoking, Snus Use and the Risk of COVID-19 in a Cohort of Adult Client of Public Dentistry Clinics: is There a Causal Association?

TypeobservationalSponsorKarolinska InstitutetRan2015 to 2023Enrolled450,000ConditionsCovid19ArmsTobacco use
NCT04927169 phase2terminatednot on this mapstarted 2021, after this paper: background citation

Recombinant Human InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic PAtients With COVID-19 Infection - "ILIAD 7 Trial" Brazil Cohort

TypeinterventionalSponsorRevimmuneRan2021 to 2022Enrolled4ConditionsCOVID-19, LymphocytopeniaArmsInterleukin-7, PLACEBO
NCT04978051 phase2completednot on this mapstarted 2021, after this paper: background citation

Randomized, Open, Multicenter Phase II Clinical Trial, Proof of Concept, to Evaluate Efficacy and Safety of Icatibant in Hospitalized Patients With SARS-COV-2 (COVID-19) Without Assisted Ventilation Compared With Standard Care

TypeinterventionalSponsorSebastian VidelaRan2021 to 2022Enrolled73ConditionsCOVID-19 PneumoniaArmsFirazyr, SoC
NCT05024500 nacompletednot on this map

Clinical, Respiratory, Peripheral, Muscle and Functionality Outcomes of Adult ICU Inpatients and Rehabilitation-center Outpatients With COVID-19

TypeinterventionalSponsorUniversity of PernambucoRan2020 to 2022Enrolled75ConditionsAcute Respiratory Distress Syndrome (ARDS)ArmsARDSNet table, Driving Pressure, Electrical Impedance Tomography
NCT05046509 completednot on this mapstarted 2021, after this paper: background citation

The Clinical Manifestations of SARS-Cov-2 Disease; Not Only Pulmonary

TypeobservationalSponsorAssiut UniversityRan2021 to 2022Enrolled445ConditionsCovid19
NCT05083013 unknown statusnot on this mapstarted 2021, after this paper: background citation

Outcomes of Diabetes In Hospitalized COVID-19 Patients At Assiut University Hospital

TypeobservationalSponsorAssiut UniversityRan2021 to 2022Enrolled160ConditionsDiabetes Mellitus, COVID-19ArmsReverse transcription polymerase chain reaction (RT-PCR), Glycated haemoglobin (HbA1C), High Resolution Computed Tomography (HRCT), Routine Laboratory investigations, Random Blood Sugar (RBS)
NCT05087394 completednot on this map

Cohort of COVID19 Patients Admitted to Pasteur Clinic 2020-2021

Typeobservational_patient_registrySponsorAsociacion Latinoamericana de ToraxRan2020 to 2022Enrolled1,500ConditionsCOVID-19ArmsComorbidities
NCT05216614 phase2withdrawnnot on this mapstarted 2021, after this paper: background citation

Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia (FluCOP Trial)

TypeinterventionalSponsorWashington University School of MedicineRan2021 to 2022Enrolled0ConditionsCOVID-19, Olfactory Disorder, ParosmiaArmsFluvoxamine, Placebo
NCT05228717 unknown statusnot on this map

Point-of-care Lung Ultrasound (POCUS)-Integrated Observation Study of Admitted Patients With COVID-19

TypeobservationalSponsorOlive View-UCLA Education & Research InstituteRan2020 to 2022Enrolled240ConditionsLung Injury, ARDS, Acute Cardiac Event, Covid19ArmsPoint of Care Ultrasound
NCT05286268 unknown statusnot on this mapstarted 2022, after this paper: background citation

The Role of Ischemia Modified Albumin in Patients With COVID-19

TypeobservationalSponsorLarissa University HospitalRan2022 to 2022Enrolled194ConditionsCOVID-19ArmsIschemia Modified Albumin
NCT05299346 completednot on this map

Post-ICU Covid19 Follow-up With Regards to Lung, Heart, Kidney and Cognitive Function

Typeobservational_patient_registrySponsorSahlgrenska University HospitalRan2020 to 2023Enrolled793ConditionsCOVID-19 Pandemic, Intensive Care Unit Syndrome, DeliriumArmsFollow up
NCT05318144 completednot on this mapstarted 2021, after this paper: background citation

Prognostic Value of Serum Melatonin as a Biomarker for the Determination of Severe COVID-19 Infection in Pregnant Women

Typeobservational_patient_registrySponsorNazan Yurtcu MDRan2021 to 2022Enrolled228ConditionsCOVID-19 Acute Respiratory Distress Syndrome, Pregnancy Related, Pregnancy Complications
NCT05348720 unknown statusnot on this map

Impact of a COVID-19 Related ICU Stay on Mental Health for Patients and Their Relatives. An Exploratory 18-month Follow-up Study for COVID-19 ICU Survivors and Their Relatives.

TypeobservationalSponsorGeneral Hospital GroeningeRan2020 to 2023Enrolled120ConditionsPost Intensive Care Syndrome, PICS, COVID-19, Critically Ill
NCT05392088 unknown statusnot on this mapstarted 2022, after this paper: background citation

Characterization and Prognostic Role of Myocardial Injury in Patients With COVID-19. The CardioCOVID Gemelli Study.

Typeobservational_patient_registrySponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2022 to 2024Enrolled1,500ConditionsMyocardial Injury, COVID-19ArmsDATA EXTRACTION, FOLLOW-UP
NCT05522387 phase2terminatednot on this mapstarted 2023, after this paper: background citation

An Open Label Extension of XPro1595 in Patients With Alzheimer's Disease That Have Completed a Phase 1 or Phase 2 Study With XPro1595

TypeinterventionalSponsorInmune Bio, Inc.Ran2023 to 2024Enrolled11ConditionsAlzheimer Disease, Dementia, Brain Diseases, Central Nervous System DiseasesArmsXPro1595
NCT05559138 completednot on this mapstarted 2022, after this paper: background citation

Analysis of Clinical Characteristics of Hemodialysis Patients With Omicron Infection

TypeobservationalSponsorRenJi HospitalRan2022 to 2022Enrolled260ConditionsCOVID-19Armsno intervention
NCT05560737 unknown statusnot on this mapstarted 2021, after this paper: background citation

ODYSSEE-vCHAT Mental Health Study: A Virtual Community Promoting Health Literacy, Self-Care, and Peer Support for Heart Failure and Kidney Disease

Typeobservational_patient_registrySponsorUniversity Health Network, TorontoRan2021 to 2023Enrolled215ConditionsChronic Heart Failure, Chronic Kidney DiseasesArmsODYSSEE-vCHAT
NCT05630339 nacompletednot on this mapstarted 2022, after this paper: background citation

Efficacy and Security of the Magnesium and Vitamin D Combination as Adjuvant Treatment of Post-COVID Syndrome. A Randomised Double-blind Clinical Trial

TypeinterventionalSponsorCoordinación de Investigación en Salud, MexicoRan2022 to 2023Enrolled150ConditionsPost-COVID-19 Syndrome, Long COVID, Vitamin D Deficiency, Magnesium DeficiencyArmsMagnesium chloride, Vitamin D, Inert placebo
NCT05736900 nacompletednot on this map

Counter-Regulatory Hormonal and Stress Systems in Patients With COVID-19

TypeinterventionalSponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2020 to 2021Enrolled200ConditionsCOVID-19ArmsBlood sampling
NCT07544186 nacompletednot on this map

Effect of a Non-pharmacological Intervention (Nutritional Therapy and Pulmonary Rehabilitation) on Endothelial Function, Body Composition, and Physical Functionality in Recovered COVID-19 Patients.

TypeinterventionalSponsorInstituto Nacional de Enfermedades RespiratoriasRan2020 to 2023Enrolled43ConditionsSupplemental Nutrition Assistance Program Education, Post COVID Syndrome, Endothelial FunctionArmsL-citrulline supplementation
3 · Its place in the literature

Who cites it

14,993 citing papers in PubMed, 5 syntheses or guidelines pooled it, 28,983 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Review
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

14,933 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Fei ZhouDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Ting YuDepartment of Tuberculosis and Respiratory Disease, Jinyintan Hospital, Wuhan, China.
Ronghui DuDepartment of Pulmonary and Critical Care Medicine, Wuhan Pulmonary Hospital, Wuhan, China.
Guohui FanDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.
Ying LiuDepartment of Tuberculosis and Respiratory Disease, Jinyintan Hospital, Wuhan, China.
Zhibo LiuDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Jie XiangDepartment of Clinical Laboratory, Jinyintan Hospital, Wuhan, China.
Yeming WangDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China.
Bin SongDepartment of Tuberculosis and Respiratory Disease, Jinyintan Hospital, Wuhan, China.
Xiaoying GuDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.
Lulu GuanDepartment of Pulmonary and Critical Care Medicine, Wuhan Pulmonary Hospital, Wuhan, China.
Yuan WeiDepartment of Tuberculosis and Respiratory Disease, Jinyintan Hospital, Wuhan, China.
Hui LiDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Xudong WuGCP Center, Jinyintan Hospital, Wuhan, China.
Jiuyang XuTsinghua University School of Medicine, Beijing, China.
Shengjin TuDepartment of Tuberculosis and Respiratory Disease, Jinyintan Hospital, Wuhan, China.
Yi ZhangDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Hua ChenDepartment of Tuberculosis and Respiratory Disease, Jinyintan Hospital, Wuhan, China. Electronic address: 2716637947@qq.com.
Bin CaoDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China; Tsinghua University School of Medicine, Beijing, China. Electronic address: caobin_ben@163.com.
Jinyintan Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNWuhan Pulmonary Hospital · CNCapital Medical University · CNTsinghua University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological and clinical characteristics of patients with COVID-19 have been reported but risk factors for mortality and a detailed clinical course of illness, including viral shedding, have not been well described.

methodsIn this retrospective, multicentre cohort study, we included all adult inpatients (≥18 years old) with laboratory-confirmed COVID-19 from Jinyintan Hospital and Wuhan Pulmonary Hospital (Wuhan, China) who had been discharged or had died by Jan 31, 2020. Demographic, clinical, treatment, and laboratory data, including serial samples for viral RNA detection, were extracted from electronic medical records and compared between survivors and non-survivors. We used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death.

findings191 patients (135 from Jinyintan Hospital and 56 from Wuhan Pulmonary Hospital) were included in this study, of whom 137 were discharged and 54 died in hospital. 91 (48%) patients had a comorbidity, with hypertension being the most common (58 [30%] patients), followed by diabetes (36 [19%] patients) and coronary heart disease (15 [8%] patients). Multivariable regression showed increasing odds of in-hospital death associated with older age (odds ratio 1·10, 95% CI 1·03-1·17, per year increase; p=0·0043), higher Sequential Organ Failure Assessment (SOFA) score (5·65, 2·61-12·23; p<0·0001), and d-dimer greater than 1 μg/mL (18·42, 2·64-128·55; p=0·0033) on admission. Median duration of viral shedding was 20·0 days (IQR 17·0-24·0) in survivors, but SARS-CoV-2 was detectable until death in non-survivors. The longest observed duration of viral shedding in survivors was 37 days.

interpretationThe potential risk factors of older age, high SOFA score, and d-dimer greater than 1 μg/mL could help clinicians to identify patients with poor prognosis at an early stage. Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future.

fundingChinese Academy of Medical Sciences Innovation Fund for Medical Sciences; National Science Grant for Distinguished Young Scholars; National Key Research and Development Program of China; The Beijing Science and Technology Project; and Major Projects of National Science and Technology on New Drug Creation and Development.

Indexed as

Organ Dysfunction ScoresPatient Care PlanningRisk AssessmentAdolescentAdultAgedAged, 80 and overAge FactorsBetacoronavirusCardiovascular DiseasesChinaClinical Laboratory TechniquesCohort StudiesComorbidityCoronavirus InfectionsCOVID-19Fibrin Fibrinogen Degradation Productsfibrin fragment D

Identifiers

PMID32171076
PMCPMC7270627
OpenAlexW3009885589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 100 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.